[1]
Moataz S. Seyam et al. 2019. Evaluation of fluvastatin in combination with the standard of care therapy (PEG-IFN/Ribavirin) in Egyptian patients with hepatitis C virus. Turkish Journal of Gastroenterology. 26, 6 (Jul. 2019), 511–516.